Robert Friel

Robert F.
Friel is Chairman at West Pharmaceutical Services, Inc. since 2026.
He is Independent Chairman at Xylem, Inc. since 2020.
He serves as Director at New York Life Insurance Co. since 2019.
He is Director at Analytical Life Science & Diagnostics Association.
He is President at PerkinElmer Life & Analytical Sciences, Inc. since 2006.
Formerly, Mr. Friel was President & Chief Executive Officer at Excelitas Technologies Sensors, Inc. He was Chairman & Chief Executive Officer at Revvity, Inc. from 2018 to 2019.
He was Chairman-Supervisory Board at EUROIMMUN Medizinische Labordiagnostika AG.
He was Director at Millennium Pharmaceuticals, Inc. from 2005 to 2008.
He was Director at Fairchild Semiconductor International LLC.
He was Independent Director at NuVasive LLC from 2016 to 2023.
He was Independent Director at CareFusion Corp.
from 2012 to 2015.
He was Treasurer & Vice President at AlliedSignal, Inc. from 1980 to 1999.
He was National Trustee at March of Dimes Foundation.
Mr. Friel completed graduate studies at Fairleigh Dickinson University and undergraduate studies at Lafayette College.